OK, if we accept the mortality rates are not significantly different, but they are different....let us assume that there is a small decrease in the newborn mortality rate with routine testing and administration of abx during labour. So some babies will be saved. Great, really, wonderful, hat's what we wall want, healthy, happy babies.
But what if the cost of saving those babies lives of preventing their admission to NICU came at the cost of endangering and losing those babies - and others - just due to different causes?
A couple of examples of what I'm talking about:
In the US, where approximately 30% of labouring women are treated with the abx for positive GBS screens in the 36th week of pregnancy, some strains of GBS are becoming antibiotic- resistant. This means that if it is passed to the baby (and the antibiotics do not always prevent this) there is no treatment. Some strains have been discovered that are resistant to ALL known antibiotics. Routine administration has created this superbug from a bacterium that naturally manifests in the vaginal and rectal region of many women.
The use of antibiotics during labour reduces the indidence of GBS infection - but it increases the likelihood of other blood infections such as E.Coli, and those are harder to treat as the infection has already been exposed to the abx and become resistant.
These considerations do not even touch on the fact that for the 30% of women who would test positive, their options for labour, pain management, and birth location would be severely curtailed. For women who test positive, there is extra worry in late pregnancy, extra hours in the hospital arriving early to administer abx, less chance of an active labour or of managing the pain with water or positioning due to IV abx. This means increased likelihood of other interventions, drugs, assisted deliveries, CS, and all those attendant complications, side effects, mental health problems, Bfing issues, and problems conceiving, keeping or birthing future pregnancies.... All worth it OF COURSE if this improved outcomes for your child. But if it doesn't, really? Is it worth doing?
It's not just a matter of offering a test. There are very far reaching implications of tethering 30% of labouring women to intravenous antibiotic in today's enviroment of antibiotic resistant superbugs.